GLP-1 drugs may prevent type 2 diabetes more effectively than metformin

GLP-1 drugs may prevent type 2 diabetes more effectively than metformin
Photo: The Times of India

Weight-loss drugs such as Ozempic and Mounjaro may be more effective than metformin in preventing type 2 diabetes in people with obesity and prediabetes.

An analysis of 256,492 adults with prediabetes and obesity found that users of GLP-1-based treatments had a 31 percent lower risk of developing the disease compared to those taking metformin.

The study, presented at the American Heart Association's Scientific Sessions 2026, also showed that patients receiving weight loss injections were about 1.5 times more likely to return their blood sugar to normal levels.

Researchers reported a 41 percent lower risk of death from any cause among those using GLP-1 medications. The benefits also extended to reduced risks of heart attack, stroke, heart failure, and atrial fibrillation.

Vinicius de Sousa Barzon Serra, a research fellow at the Mayo Clinic, said the findings suggest these medications may offer benefits beyond weight loss. He suggested that prediabetes may be a good time to discuss GLP-1 medications with patients instead of waiting for diabetes to develop.

Bradley Neutel, an endocrinologist, said confounding factors like age, obesity severity, and comorbidities need to be considered.

Key facts

  • GLP-1-based drugs were associated with a 31 percent lower risk of developing type 2 diabetes compared to metformin.
  • Users of GLP-1 medications had a 41 percent lower risk of death from any cause.
  • The study analyzed 256,492 adults with obesity and prediabetes.

Three perspectives

Neutral

The study compared the outcomes of adults with prediabetes and obesity using GLP-1 receptor agonists against those using metformin.

Positive

Patients taking weight loss injections had a 50 percent higher relative chance of returning their sugar levels to normal compared to those using metformin.

Negative

The observational study does not definitively prove that the drugs directly caused the reported benefits.

Your week in news, every Wednesday

The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.

Choose your news coverage

Please choose and confirm your coverage.

All sections

Edition